Please provide your email address to receive an email when new articles are posted on . In a cross-sectional analysis of adults who attended outpatient clinics at the University of Florida in ...
Liver steatosis is more prevalent than liver fibrosis in people with HIV, with significant risk factors including age, hypertension, and diabetes. Liver fibrosis prevalence is low, with integrase ...
Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately ...
Please provide your email address to receive an email when new articles are posted on . More than half of patients with baseline fatty liver disease experienced a reduction in hepatic steatosis after ...
Background: Biopsy is the usual gold standard for liver steatosis assessment. The aim of this study was to identify a panel of biomarkers (SteatoTest), with sufficient predictive values, for the ...
A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a 61-patient cohort, those with the ...
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives disease progression to intrahepatic conditions such as ...
Solute carrier (SLC) family transporters are crucial transmembrane proteins responsible for transporting various molecules, including amino acids, electrolytes, fatty acids, and nucleotides. To date, ...
Comparison of colorectal cancer (CRC) characteristics across genetic ancestries: Implications for early cancer detection (ECD). This is an ASCO Meeting Abstract from the 2024 ASCO Gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results